Evaluation of Platelet Rich Plasma in the Management of Psoriasis
Abd-El Rahman, S., Salem, R., Ahmed, A. (2018). Evaluation of Platelet Rich Plasma in the Management of Psoriasis. EKB Journal Management System, 3(1), 21-25. doi: 10.21608/bjas.2018.179330
S.H. Abd-El Rahman; R.M. Salem; A.H. Ahmed. "Evaluation of Platelet Rich Plasma in the Management of Psoriasis". EKB Journal Management System, 3, 1, 2018, 21-25. doi: 10.21608/bjas.2018.179330
Abd-El Rahman, S., Salem, R., Ahmed, A. (2018). 'Evaluation of Platelet Rich Plasma in the Management of Psoriasis', EKB Journal Management System, 3(1), pp. 21-25. doi: 10.21608/bjas.2018.179330
Abd-El Rahman, S., Salem, R., Ahmed, A. Evaluation of Platelet Rich Plasma in the Management of Psoriasis. EKB Journal Management System, 2018; 3(1): 21-25. doi: 10.21608/bjas.2018.179330

Evaluation of Platelet Rich Plasma in the Management of Psoriasis

Benha Journal of Applied Sciences
Article 5, Volume 3, Issue 1, March 2018, Page 21-25  XML PDF (453.29 K)
Document Type: Original Research Papers
DOI: 10.21608/bjas.2018.179330
View on SCiNiTO View on SCiNiTO
Authors
S.H. Abd-El Rahman1; R.M. Salem2; A.H. Ahmed3
1Assistant Professor of Dermatology,Venereology and Andrology Dept., Faculty of Medicine, Benha Univ., Benha, Egypt
2Lecturer of Dermatology,Venereology and Andrology Dept., Faculty of Medicine, Benha Univ.,Benha, Egypt
3Resident of Dermatology,Venereology and Andrology Dept., Faculty of Medicineone Day Surgery El Basatine, Egypt
Abstract
Psoriasis is a chronic immune-mediated disease affecting approximately 2–3% of general population. It is
associated with significant negative impact on patient’s physical and psychological quality of life along with
vulnerability to co-morbidities such as cardiometabolic dysfunction, depression, and so on [1]. to evaluate the
efficiency of platelet rich plasma (PRP) in the management of patients with chronic localized recalcitrant plaque
psoriasis.This was a prospective pilot study conducted on 30 cases with chronic localized recalcitrant psoriasis
attended Dermatology, Venereology and Andrology outpatient clinics, Benha University Hospitalis. This study was
approved by Dermatology, Venereology and Andrology Department and Ethics Commitee in the Faculty of
Medicine, Benha University. The study details were discussed with all patients and informed consents were
obtained from them before the begining of the study.PASI score had significantly decreased in group I after 8 and 16
weeks of treatment when compared to the baseline (p =0.001). There was also significant decrease in PASI score between
week 8, 16 (p =0.0018). PASI score showed no significant difference in group II neither at week 8 nor 16 compared to
baseline (p =0.894).
Supplementary Files
Statistics
Article View: 75
PDF Download: 364